Related Experiment Video
Updated: Jun 29, 2025
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
Published on: December 17, 2010
[Idiopathic hypertrophic pachymeningitis]
P G Shnyakin1,2, N V Isaeva1,2, M I Severina1,2
1Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
Abstract:
The article presents a case of idiopathic hypertrophic pachymeningitis of a 61-year-old male patient with severe cephalgia and progressive neuropathy of the oculomotor nerves. The diagnosis was confirmed by MRI with gadolinium, which revealed thickening of the dura mater with accumulation of paramagnetic in the convexital parts of the frontal and temporal regions, as well as on the base of the skull and tentorium. During the use of pulse therapy with glucocorticosteroids (GCS) the symptoms regressed, but when the therapy was stopped, there was a relapse of ptosis and oculomotor abnormalities on the other side followed by a slower effect of GCS therapy. The article also presents a brief review of current knowledge about this pathology.
Insights
Idiopathic hypertrophic pachymeningitis, a rare dural thickening condition, can cause severe headaches and cranial nerve issues. Glucocorticosteroid therapy offers symptom relief but relapses may occur, necessitating ongoing management.
Area of Science:
- Neurology
- Radiology
- Immunology
Background:
- Idiopathic hypertrophic pachymeningitis (IHP) is a rare, chronic inflammatory condition characterized by thickening of the dura mater.
- It can lead to significant neurological deficits due to compression of neural structures.
- Accurate diagnosis and effective management strategies are crucial for patient outcomes.
Observation:
- A 61-year-old male presented with severe cephalgia and progressive oculomotor nerve neuropathy.
- MRI with gadolinium revealed dural thickening in the cranial convexity and base, consistent with IHP.
- Initial pulse therapy with glucocorticosteroids (GCS) led to symptom regression.
Findings:
- Discontinuation of GCS therapy resulted in a relapse of ptosis and contralateral oculomotor abnormalities.
- Subsequent GCS treatment showed a slower therapeutic effect, indicating potential for disease recurrence or resistance.
- The case highlights the complex and relapsing-natural course of IHP.
Implications:
- This case underscores the importance of vigilant monitoring and potentially long-term management for IHP patients.
- Understanding the inflammatory pathways involved in IHP may lead to novel therapeutic targets.
- Further research into the long-term efficacy and optimal duration of GCS therapy in IHP is warranted.
More Related Videos
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology